Gordon Joseph F 4

4 · Bausch Health Companies Inc. · Filed Mar 10, 2021

Form 4

Period: 2021-03-08

President Bausch & Lomb/Int'l

Transactions

Award
Common Shares, No Par Value
2021-03-08+17,320→ 123,099 total
Exercise/Conversion
Restricted Share Units
2021-03-08−5,637→ 0 total
Exp: 2021-03-07→ Common Shares, No Par Value (5,637 underlying)
Exercise/Conversion
Common Shares, No Par Value
2021-03-08+5,637→ 105,779 total
Tax Payment
Common Shares, No Par Value
2021-03-10$32.97/sh−12,461$410,839→ 110,638 total

Footnotes (5)

[F1]Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018.
[F2]Each PSU converts into Common Shares on a one-for-one basis.
[F3]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs.
[F4]The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics.
[F5]This PSU award was previously reported on a Form 3 filed on August 10, 2018 with the target potential award amount of 4,546 shares.

Documents

1 file